15 August 2025 in BJPsych Open
Background: Catatonia, a neuropsychiatric syndrome, can be associated with inflammatory conditions of the central nervous system. Aims: To explore steroid-responsive catatonia with possible autoimmune origins. Method: A retrospective investigation was conducted of clinical and paraclinical features, including imagining, serum, and cerebrospinal fluid findings in ten patients presenting with subacute onset catatonia and treated with steroid pulse therapy between January 2022 and January 2024. Results: A retrospective chart review identified ten patients (of a total of 56) with steroid-responsive subacute onset catatonia. Catatonia types varied. All patients were positive for delirium and psychotic symptoms. Imaging and cerebrospinal fluid results indicated non-specific signs of central nervous system inflammation. Intravenous 1 g methylprednisolone pulse therapy resulted in complete remission in all patients. Autoantibodies for limbic and paraneoplastic encephalitis were negative for all patients. None of the patients fulfilled the criteria for definite autoimmune encephalitis or autoantibody-negative probable autoimmune encephalitis. Conclusions: Diagnosis of autoimmune catatonia is challenging without autoantibody markers, but steroid responsiveness, combined with clinical and paraclinical features, may suggest an autoimmune mechanism.
1 January 2018 in Turkish Journal of Psychiatry
VSVesile Senturk-Cankorur
The aim of this study was to investigate psychosocial functioning of euthymic Bipolar Disorder Type-II (BD-II) patients and the association between psychosocial functioning with cognitive functions and subclinical symptoms. The hypothesis was BD-II patients would have low level of psychosocial functioning comparing to healthy subjects and psychosocial functioning would be associated independently with cognitive dysfunction and subclinical symptoms. Thirthy-three subjects who met criteria for BD-II according to Structured Clinical Interview for DSM-IV and thirty-five healthy subjects were included. Clinical symptoms were assessed by Hamilton Depression Rating Scale (HDRS), Young Mania Rating Scale (YMRS); Hamilton Anxiety Rating Scale (HARS); psychosocial functioning was assessed by Functioning Assessment Short Test (FAST). Neurocognitive assessment battery was consisted of WAIS-R general information subtest; Wisconsin Card Sorting Test (WCST) perseverative errors, nonperseverative errors and category completed subtests; Trail Making Test-B (TMT-B); Stroop TBAG form; Trail Making Test-A(TMT-A) Auditory Consonant Trigrams (ACT) ACT; Wechsler Memory Scale Revised (WMS-R). Clinical symptoms assessed by HDRS, HARS scores; psychosocial functioning scores assessed by FAST; neurocognitive functions assessed by WCST category completed and, TMT-B, Stroop test, TMT-A, ACT, and WMS-R scores were significantly different between the two groups. FAST scores were associated with ACT scores in BB-II group. BB-II patients had cognitive dysfunctions and low level of psychosocial functioning even in their euthymic states. Working memory dysfunction was independently associated with psychosocial functioning of euthymic BB-II patients.
1 January 2021 in Adolescent Psychiatry
Background: Understanding adolescents' and emerging adults' psychiatric complaints and their relations with psychiatric disorders can be challenging. Beier Sentence Completion Test (BSCT), as a projective test, can be promising in this respect. However, relations between BSCT profiles and adolescent psychopathology are not well known. Aim: This study aimed to examine and compare BSCT profiles of adolescents and emerging adults with internalizing and externalizing disorders. As well as that, the relation of BSCT profiles with depression and anxiety scores was investigated. Objective: To achieve this aim, we retrospectively collected the hospital records of 300 adolescents and emerging adults (aged. 14-21) admitted to an Adolescent Psychiatry Outpatient Unit. Methods: The psychiatric diagnosis of the patients was classified as Internalizing (n = 100) and Externalizing (n = 100) disorder groups; the control group (n = 100) consisted of adolescents and young adults without any psychiatric diagnosis. BSCT, the Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) were administered on the first admission to all cases before psychiatric evaluation and treatment. BSCT total subfactor (positive, negative, neutral, and non-response) statement scores were compared between groups, and their correlations with BDI and BAI were investigated. Besides, multivariate logistic regression analyses were conducted for estimating any diagnostic group differences, as well as bivariate logistic regression analyses for estimating BDI and BAI cutoff scores with models that included BSCT total subfactor statement scores. Results: It was revealed that lower positive and non-response statements were crucial for distinguishing externalizing and internalizing disorders and that positive and negative statements were correlated with depression and anxiety scores.In the multivariate regression model, these correlations were predictive only for the relationship between internalizing disorders group and low positive statement scores, not higher negative statement scores that can be associated with lack of positive emotional processing in this group. Also, non response statement scores were found to be predictive for externalizing disorder groups. Similarly, BDI cut-off scores were predicted with low positive statement scores. Conclusion: BSCT profiles can be promising for understanding adolescents and emerging adults with internalizing and externalizing disorders. Lack of positive attributions to the self and other domains of life can be important for differentiating adolescent psychopathology.
10 September 2025 in Frontiers in Psychiatry
Introduction: Hashimoto’s encephalopathy (HE) is a rare neuro-inflammatory disorder that poses a significant diagnostic challenge, particularly when its clinical presentation is dominated by psychiatric symptomatology. This study aimed to delineate the constellation of clinical and paraclinical features that differentiate HE from primary psychiatric disorders among seropositive inpatients, thereby facilitating its early and accurate identification.Methods: In this retrospective, single-center study, the records of 484 consecutively admitted female psychiatric inpatients were reviewed. The final cohort comprised 40 patients with confirmed thyroid autoantibody seropositivity. Patients presenting with atypical features or suspected autoimmune etiologies were subjected to a comprehensive neurodiagnostic evaluation, including cerebrospinal fluid (CSF) analysis, electroencephalography (EEG), MRI, and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). The diagnosis of HE was established based on stringent criteria, including the exclusion of alternative etiologies and a definitive therapeutic response to corticosteroids.Results: Of the 40 seropositive patients, nine (22.5%) met the diagnostic criteria for definitive HE. The HE cohort exhibited a significantly later age of psychiatric symptom onset (42.9 vs. 30.1 years; p=0.011) and markedly greater functional impairment (GAF score: 31.7 vs. 51.6; p<0.001) compared to the non-HE group. The most discriminating clinical features were delirium (88.9% in HE vs. 6.5% in non-HE; p<0.001) and catatonia (77.8% vs. 32.3%; p=0.015). Corroborating neurodiagnostic evidence for HE included inflammatory CSF abnormalities (55.6% vs. 0%), diffuse EEG slowing (33.3% vs. 0%), and cortical hypometabolism on FDG-PET (85.7% vs. 0%). All patients with HE were refractory to standard psychiatric interventions but achieved prompt and substantial clinical remission following high-dose corticosteroid administration.Discussion: In conclusion, HE manifests as a distinct and severe neuropsychiatric syndrome in a subset of seropositive psychiatric inpatients. The emergence of a late-onset clinical picture characterized by a delirium-catatonia complex, particularly when refractory to conventional psychiatric treatment, warrants a high index of suspicion for HE. A multimodal diagnostic approach is essential for accurate identification, enabling the timely initiation of immunotherapy to ameliorate severe neuropsychiatric morbidity and prevent long-term disability
14 November 2025 in Frontiers in Psychiatry
VCVesile Şentürk Cankorur
Introduction: This study aimed to compare the neurocognitive profiles of euthymic patients with bipolar I (BD-I) and bipolar II (BD-II) disorder and healthy controls, while controlling for confounding clinical and pharmacological variables, to determine whether observed cognitive differences reflect true subtype distinctions or are secondary to illness burden. Methods: We assessed 78 clinically stable outpatients with BD-I or BD-II and 40 healthy controls using a comprehensive neuropsychological battery that included tests of verbal episodic memory, executive functioning, processing speed, attention, and working memory. All patients were in euthymia and receiving stable monotherapy. Analyses of covariance (ANCOVA) were conducted to compare group performance, adjusting for age, illness duration, number of depressive episodes, hospitalizations, and chlorpromazine-equivalent doses of antipsychotics and mood stabilizers. Results: Both BD subtypes demonstrated significant cognitive impairments relative to controls. BD-I patients showed broader and more severe deficits, especially in verbal episodic memory and executive flexibility. Importantly, only verbal memory impairments remained significant after full covariate adjustment, indicating a potential trait-like vulnerability in BD-I. Differences in executive function, processing speed, and attention between BD-I and BD-II were primarily explained by illness severity and medication exposure. Verbal episodic memory represents a robust and subtype-specific cognitive impairment in BD-I, whereas other cognitive differences between BD-I and BD-II are primarily attributable to modifiable clinical factors. Discussion: These findings underscore the importance of integrating cognitive evaluation into routine care and suggest that cognitive profiles may inform personalized interventions and diagnostic clarification in bipolar disorder.
29 July 2021 in Turkish Journal of Child and Adolescent Mental Health